about
Antifibrinolytics (lysine analogues) for the prevention of bleeding in people with haematological disordersTranexamic acid for reducing mortality in emergency and urgent surgeryAntifibrinolytics (lysine analogues) for the prevention of bleeding in patients with haematological disordersTranexamic acid for reducing mortality in emergency and urgent surgeryAnti-fibrinolytics (lysine analogues) for the prevention of bleeding in patients with haematological disordersTwo distinct coagulase-dependent barriers protect Staphylococcus aureus from neutrophils in a three dimensional in vitro infection modelTranexamic acid in pediatric trauma: why not?The pre-hospital administration of tranexamic acid to patients with multiple injuries and its effects on rotational thrombelastometry: a prospective observational study in pre-hospital emergency medicine.The contemporary role of blood products and components used in trauma resuscitation.Update and new developments in the management of the exsanguinating patient.Antifibrinolytic therapy in the management of aneurismal subarachnoid hemorrhage revisited. A meta-analysis.Hemoglobin-based oxygen carriers promote systemic hyperfibrinolysis that is both dependent and independent of plasmin.Effectiveness of early administration of tranexamic acid in patients with severe trauma.The expanding role of tranexamic acid in the management of obstetric hemorrhage.The use of anti-fibrinolytic agents in patients with HHT: a retrospective survey.Biomaterials and Advanced Technologies for Hemostatic Management of Bleeding.Single perioperative dose of tranexamic acid in primary hip and knee arthroplasty.Comparison of oral versus intra-articular tranexamic acid in enhanced-recovery primary total knee arthroplasty without tourniquet application: a randomized controlled trial.
P2860
Q24186028-A2EBF89D-5971-4FC8-B91D-296898FBC786Q24197621-C9EEC3D8-5EC9-4E5C-9EB1-A8BD8C0BDF52Q24201018-2A9DE21A-1351-428B-B9B5-3C26865823DDQ24201503-079C101E-934F-455F-84AF-32A99C44207DQ24201514-276F9A1E-814F-4020-9C76-6AEB59E62FA2Q27347982-AFB2B234-7572-4D2E-92A3-941CC92155AFQ33892479-905CF8DA-0341-4477-A5B8-EECE8071E141Q37326282-1C7041FA-29CE-4532-A77D-D210BA3FDD0AQ37812157-5420F7E1-51F4-40D2-A7AE-D16C2B8AA7A5Q37900080-BCE6DD4C-287B-4BAF-B5D5-370D73633DD4Q37946256-FA2DF4E9-87F5-4D71-8FAB-CD86759E5B4CQ38732501-68E9325D-3E6D-4C42-A5BC-4A1D955368E7Q38946580-854A17F6-BDB4-4083-B2F7-378B4F9C9945Q42357335-22E1EF72-D8F3-4B3C-804B-6C7FB5442BA2Q43814638-C36C3D9B-0250-423A-B349-19E78643637DQ47324534-3D0566F5-539A-4DC7-BDCF-66E1D6D00AF9Q50473233-97257797-A044-4AC8-B96D-A38EB5DA3297Q51739699-0A4183E5-6138-4741-9147-C08EAACA186E
P2860
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
1997年论文
@zh
1997年论文
@zh-cn
name
Enzyme-controlling medicines: introduction.
@en
type
label
Enzyme-controlling medicines: introduction.
@en
prefLabel
Enzyme-controlling medicines: introduction.
@en
P2093
P356
P1476
Enzyme-controlling medicines: introduction.
@en
P2093
A Hijikata-Okunomiya
P304
P356
10.1055/S-2007-996127
P577
1997-01-01T00:00:00Z